The lab on chip market size has grown rapidly in recent years. It will grow from $8.85 billion in 2025 to $10.02 billion in 2026 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to advancements in microfluidics technology, growth in diagnostic testing demand, increasing research funding, need for faster clinical results, expansion of biotechnology research.
The lab on chip market size is expected to see rapid growth in the next few years. It will grow to $16.25 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to growth of decentralized healthcare testing, rising adoption in resource-limited settings, integration with digital health platforms, expansion of personalized diagnostics, increasing use in drug discovery. Major trends in the forecast period include miniaturization of diagnostic devices, growth of point of care testing, integration of multiple lab functions on chip, increased use of microfluidics, rising demand for rapid diagnostics.
The increasing use of personalized medicine is expected to drive the growth of the lab-on-chip market due to its ability to provide quick, accurate, and cost-efficient genetic analysis for customized treatments. Personalized medicine tailors prevention and treatment based on an individual’s genetic profile, lifestyle, and environment. The growth of personalized medicine is fueled by advancements in genetic testing, allowing treatments to align with an individual’s genetic makeup, which increases effectiveness and reduces side effects. Lab-on-chip devices facilitate rapid and precise analysis of genetic and molecular data, enabling personalized treatments while lowering both time and costs compared to traditional laboratory techniques. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization in the United States, reported that the FDA approved 16 personalized therapies in 2023 aimed at treating rare diseases, a significant increase from the six treatments approved in 2022. As a result, the expanding use of personalized medicine is boosting the lab-on-chip market.
Companies in the lab-on-chip market are investing in the development of advanced technologies, such as organ-on-chip systems, to speed up disease modeling and enhance applications in personalized medicine. These microfluidic devices mimic human organ functions and structures, offering precise simulations of biological processes for accurate drug testing and disease modeling outside the body. In September 2023, NETRI, a France-based provider of neuro-organs-on-chip technologies, introduced organ-on-chip kits designed to improve preclinical testing speed and predictiveness. By incorporating organ-on-chip systems into healthcare research, these kits support the use of cells from various species, enabling cross-species studies and delivering predictive clinical insights. This development accelerates drug candidate evaluation and reduces the reliance on animal testing, marking a significant advancement in the adoption of organs-on-chip technology in medical research.
In October 2024, Quris-AI, a US-based company focused on AI-driven drug development and safety prediction, acquired Nortis to strengthen its Bio-AI platform. The acquisition, for an undisclosed sum, enables Quris-AI to integrate Nortis’s advanced organ-on-chip technologies into its platform, improving the predictive capabilities for preclinical drug testing. Nortis, based in the United States, is known for its microphysiology systems, including validated kidney-on-chip technologies, which are used in biomedical research and drug development.
Major companies operating in the lab on chip market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd, QuantuMDx Group Ltd., InSphero, Micronit B.V., MesoBioTech, Mimetas, Achira Labs Pvt. Ltd., Elvesys, Beonchip, Lab Chip Technologies, Sphere Bio.
North America was the largest region in the lab on chip market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab on chip market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lab on chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have disrupted the lab on chip market by increasing costs of semiconductors, microfabrication equipment, and specialty materials. Asia-Pacific regions such as China and Taiwan are most impacted, affecting global supply chains for diagnostic chips. These costs have slowed adoption in academic and clinical settings. Positively, tariffs are driving domestic fabrication, supplier diversification, and innovation in cost-efficient LOC platforms.
The lab on chip market research report is one of a series of new reports that provides lab on chip market statistics, including lab on chip industry global market size, regional shares, competitors with a lab on chip market share, detailed lab on chip market segments, market trends and opportunities, and any further data you may need to thrive in the lab on chip industry. This lab on chip market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Lab on chip (LOC) is a compact device that integrates multiple laboratory functions, including chemical analysis, biological assays, and diagnostics, onto a single chip. It precisely controls tiny fluid volumes, enabling faster, cost-effective, and high-throughput testing. LOC devices provide portable, efficient, and accurate laboratory analyses while minimizing reagent use and reducing turnaround times.
The primary types of lab on chip products and services include reagents and consumables, instruments, and software and services. Reagents and consumables are essential materials for performing biological and chemical assays. LOC devices employ technologies such as microfluidics, micro-electro-mechanical systems (MEMS), nanolithography, and three-dimensional (3D) printing, using materials such as polymers, glass, silicon, and paper. Applications span genomics, proteomics, point-of-care diagnostics, drug discovery, and other areas. Primary end users include biotechnology and pharmaceutical companies, hospitals, diagnostic centers, academic and research institutes, and others.
The lab on chip market consists of revenues earned by entities by providing services such as medical diagnostics, drug development and screening, point-of-care testing, and cell and tissue studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab on chip market also includes sales of microfluidic analytical kits, genetic testing chips, organ-on-a-chip systems, and environmental monitoring chips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The lab on chip market size is expected to see rapid growth in the next few years. It will grow to $16.25 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to growth of decentralized healthcare testing, rising adoption in resource-limited settings, integration with digital health platforms, expansion of personalized diagnostics, increasing use in drug discovery. Major trends in the forecast period include miniaturization of diagnostic devices, growth of point of care testing, integration of multiple lab functions on chip, increased use of microfluidics, rising demand for rapid diagnostics.
The increasing use of personalized medicine is expected to drive the growth of the lab-on-chip market due to its ability to provide quick, accurate, and cost-efficient genetic analysis for customized treatments. Personalized medicine tailors prevention and treatment based on an individual’s genetic profile, lifestyle, and environment. The growth of personalized medicine is fueled by advancements in genetic testing, allowing treatments to align with an individual’s genetic makeup, which increases effectiveness and reduces side effects. Lab-on-chip devices facilitate rapid and precise analysis of genetic and molecular data, enabling personalized treatments while lowering both time and costs compared to traditional laboratory techniques. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization in the United States, reported that the FDA approved 16 personalized therapies in 2023 aimed at treating rare diseases, a significant increase from the six treatments approved in 2022. As a result, the expanding use of personalized medicine is boosting the lab-on-chip market.
Companies in the lab-on-chip market are investing in the development of advanced technologies, such as organ-on-chip systems, to speed up disease modeling and enhance applications in personalized medicine. These microfluidic devices mimic human organ functions and structures, offering precise simulations of biological processes for accurate drug testing and disease modeling outside the body. In September 2023, NETRI, a France-based provider of neuro-organs-on-chip technologies, introduced organ-on-chip kits designed to improve preclinical testing speed and predictiveness. By incorporating organ-on-chip systems into healthcare research, these kits support the use of cells from various species, enabling cross-species studies and delivering predictive clinical insights. This development accelerates drug candidate evaluation and reduces the reliance on animal testing, marking a significant advancement in the adoption of organs-on-chip technology in medical research.
In October 2024, Quris-AI, a US-based company focused on AI-driven drug development and safety prediction, acquired Nortis to strengthen its Bio-AI platform. The acquisition, for an undisclosed sum, enables Quris-AI to integrate Nortis’s advanced organ-on-chip technologies into its platform, improving the predictive capabilities for preclinical drug testing. Nortis, based in the United States, is known for its microphysiology systems, including validated kidney-on-chip technologies, which are used in biomedical research and drug development.
Major companies operating in the lab on chip market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd, QuantuMDx Group Ltd., InSphero, Micronit B.V., MesoBioTech, Mimetas, Achira Labs Pvt. Ltd., Elvesys, Beonchip, Lab Chip Technologies, Sphere Bio.
North America was the largest region in the lab on chip market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab on chip market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lab on chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have disrupted the lab on chip market by increasing costs of semiconductors, microfabrication equipment, and specialty materials. Asia-Pacific regions such as China and Taiwan are most impacted, affecting global supply chains for diagnostic chips. These costs have slowed adoption in academic and clinical settings. Positively, tariffs are driving domestic fabrication, supplier diversification, and innovation in cost-efficient LOC platforms.
The lab on chip market research report is one of a series of new reports that provides lab on chip market statistics, including lab on chip industry global market size, regional shares, competitors with a lab on chip market share, detailed lab on chip market segments, market trends and opportunities, and any further data you may need to thrive in the lab on chip industry. This lab on chip market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Lab on chip (LOC) is a compact device that integrates multiple laboratory functions, including chemical analysis, biological assays, and diagnostics, onto a single chip. It precisely controls tiny fluid volumes, enabling faster, cost-effective, and high-throughput testing. LOC devices provide portable, efficient, and accurate laboratory analyses while minimizing reagent use and reducing turnaround times.
The primary types of lab on chip products and services include reagents and consumables, instruments, and software and services. Reagents and consumables are essential materials for performing biological and chemical assays. LOC devices employ technologies such as microfluidics, micro-electro-mechanical systems (MEMS), nanolithography, and three-dimensional (3D) printing, using materials such as polymers, glass, silicon, and paper. Applications span genomics, proteomics, point-of-care diagnostics, drug discovery, and other areas. Primary end users include biotechnology and pharmaceutical companies, hospitals, diagnostic centers, academic and research institutes, and others.
The lab on chip market consists of revenues earned by entities by providing services such as medical diagnostics, drug development and screening, point-of-care testing, and cell and tissue studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab on chip market also includes sales of microfluidic analytical kits, genetic testing chips, organ-on-a-chip systems, and environmental monitoring chips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Lab on Chip Market Characteristics
3. Lab on Chip Market Supply Chain Analysis
4. Global Lab on Chip Market Trends and Strategies
5. Lab on Chip Market Analysis of End Use Industries
7. Global Lab on Chip Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Lab on Chip Total Addressable Market (TAM) Analysis for the Market
9. Lab on Chip Market Segmentation
10. Lab on Chip Market Regional and Country Analysis
11. Asia-Pacific Lab on Chip Market
12. China Lab on Chip Market
13. India Lab on Chip Market
14. Japan Lab on Chip Market
15. Australia Lab on Chip Market
16. Indonesia Lab on Chip Market
17. South Korea Lab on Chip Market
18. Taiwan Lab on Chip Market
19. South East Asia Lab on Chip Market
20. Western Europe Lab on Chip Market
21. UK Lab on Chip Market
22. Germany Lab on Chip Market
23. France Lab on Chip Market
24. Italy Lab on Chip Market
25. Spain Lab on Chip Market
26. Eastern Europe Lab on Chip Market
27. Russia Lab on Chip Market
28. North America Lab on Chip Market
29. USA Lab on Chip Market
30. Canada Lab on Chip Market
31. South America Lab on Chip Market
32. Brazil Lab on Chip Market
33. Middle East Lab on Chip Market
34. Africa Lab on Chip Market
36. Lab on Chip Market Competitive Landscape and Company Profiles
37. Lab on Chip Market Other Major and Innovative Companies
40. Lab on Chip Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Lab On Chip Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses lab on chip market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for lab on chip? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab on chip market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product And Service: Reagents And Consumables; Instruments; Software And Services2) By Technology: Microfluidics-Based Technology; Micro-Electro-Mechanical Systems (MEMS); Nanolithography; Three-Dimensional (3D) Printing Technology
3) By Material: Polymers; Glass; Silicon; Paper
4) By Application: Genomics; Proteomics; Point Of Care Diagnostics; Drug Discovery; Other Applications
5) By End-User: Biotechnology And Pharmaceuticals Companies; Hospitals; Diagnostics Centers; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Reagents And Consumables: Enzymes And Buffers; Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Kits; Microfluidic Cartridges; Microplates And Pipette Tips; Stains And Dyes2) By Instruments: Microfluidic Analyzers; Lab-On-A-Chip Readers; Fluid Handling Systems; Imaging And Detection Systems; Automation And Robotics Platforms
3) By Software And Services: Data Analysis Software; Lab Management Software; Simulation And Modeling Software; Custom Development Services; Maintenance And Support Services
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck KGaA; Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; Illumina Inc.; Revvity Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Tecan Group Ltd; QuantuMDx Group Ltd.; InSphero; Micronit B.V.; MesoBioTech; Mimetas; Achira Labs Pvt. Ltd.; Elvesys; Beonchip; Lab Chip Technologies; Sphere Bio.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Lab on Chip market report include:- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies Inc.
- Illumina Inc.
- Revvity Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Tecan Group Ltd
- QuantuMDx Group Ltd.
- InSphero
- Micronit B.V.
- MesoBioTech
- Mimetas
- Achira Labs Pvt. Ltd.
- Elvesys
- Beonchip
- Lab Chip Technologies
- Sphere Bio.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.02 Billion |
| Forecasted Market Value ( USD | $ 16.25 Billion |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
